ReachMD

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

Vizitează neapărat site-ul podcastului și susține-i creatorul: reachmd.com

Autor

ReachMD

Categorie

Science

Site-ul podcastului

reachmd.com

Cel mai nou episod

5 oct. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android aproape 10 mil. descărcări · nota 4,8 iOS în curând

Episoade

Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages 31.12.2025

Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Jonathan Strober and Diana Castro examine the diagnostic approach to generalized myasthenia gravis (gMG), with a focus on age-related differences in clinical presentation. They describe early signs in pediatric patients—such as ptosis and impaired extraocular movements—and contrast these with the fluctuating fatigue, bulbar involvement,...

Case Review: Targets Are Met—Can You Stick the Landing? 31.12.2025

Faculty: David Rubin, MD Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. The...

Switching Strategies: Switch or Stay—What’s Your Call? 31.12.2025

Faculty: David Rubin, MD Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets....

Remission: Can You Prove It? 31.12.2025

Faculty: David Rubin, MD Faculty: Kimberly D. Orleck, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. T...

Treat-to-Target: Are We There Yet? 31.12.2025

Faculty: Kimberly D. Orleck, PA-C Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic tar...

Case Review: Can You Crack This IBD Case? 31.12.2025

Faculty: David Rubin, MD Faculty: Kimberly D. Orleck, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets. T...

Tailoring Treatment: Can You Select the Best Therapy? 31.12.2025

Faculty: David Rubin, MD Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic targets....

IBD Immunopathogenesis: Do You Know What You're Blocking? 31.12.2025

Faculty: Kimberly D. Orleck, PA-C Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic...

Severity Assessment: Can You Pin the Stage on the Patient? 31.12.2025

Faculty: Jennifer Geremia, PA-C Faculty: Brooke Hodnick, PA-C, MPAS This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic t...

Diagnosing IBD: Is It IBD or Something Else? Can You Tell? 31.12.2025

Faculty: Kimberly D. Orleck, PA-C Faculty: Jennifer Geremia, PA-C This educational series guides clinicians through the full continuum of inflammatory bowel disease (IBD) care, from diagnosis to long-term management. Learners begin by distinguishing IBD from other gastrointestinal disorders and assessing disease severity, then explore the underlying immunopathogenesis to understand therapeutic tar...

Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients 31.12.2025

Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Diana Castro and Jonathan Strober discuss treatment strategies for generalized myasthenia gravis (gMG), focusing on pediatric and adolescent care. They review traditional therapies and newer agents, such as FcRn and complement inhibitors, highlighting the role of antibody status and considerations for thymectomy. The conversation also ad...

Practical Perspectives in Myasthenia Gravis #2: Patient Stratification and Antibody Profiling—Personalizing the Disease Lens 31.12.2025

Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD This discussion between Drs. Diana Castro and Jonathan Strober focuses on the clinical utility of patient stratification and antibody profiling in generalized myasthenia gravis (gMG). The conversation addresses how age of onset, antibody status (acetylcholine receptor, MuSK, LRP4), and comorbidities can influence diagnosis and management plan...

Practical Perspectives in Myasthenia Gravis # 1: Diagnostic Logistics—Navigating Complexity Across Ages 31.12.2025

Faculty: Diana Castro, MD Faculty: Jonathan Strober, MD Drs. Jonathan Strober and Diana Castro examine the diagnostic approach to generalized myasthenia gravis (gMG), with a focus on age-related differences in clinical presentation. They describe early signs in pediatric patients—such as ptosis and impaired extraocular movements—and contrast these with the fluctuating fatigue, bulbar involvement,...

Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE 30.12.2025

Faculty: Erin Bohula, MD, DPhil Faculty: Lawrence Leiter This program explores evolving strategies for low-density lipoprotein cholesterol (LDL-C) management in patients at high cardiovascular (CV) risk who have not yet experienced a myocardial infarction or stroke. Drs. Bohula and Leiter discuss unmet needs, shifting LDL-C targets, and emerging treatment strategies, including PCSK9 inhibitors and...

Earlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE 30.12.2025

Faculty: Erin Bohula, MD, DPhil Faculty: Lawrence Leiter This program explores evolving strategies for low-density lipoprotein cholesterol (LDL-C) management in patients at high cardiovascular (CV) risk who have not yet experienced a myocardial infarction or stroke. Drs. Bohula and Leiter discuss unmet needs, shifting LDL-C targets, and emerging treatment strategies, including PCSK9 inhibitors and...

A New Paradigm in IgAN Management—Advancing Clinical Practice in the Era of Therapeutic Expansion 29.12.2025

Host: Andrew S. Bomback, MD, MPH Guest: Kelly B. Chen, MSN, AGACNP-BC Guest: Duvuru Geetha, MD On-demand webcast on the latest advances in diagnosing and managing patients with IgA nephropathy (IgAN), including the current data on new and emerging IgAN therapies.

A New Paradigm in IgAN Management—Advancing Clinical Practice in the Era of Therapeutic Expansion 29.12.2025

Host: Andrew S. Bomback, MD, MPH Guest: Kelly B. Chen, MSN, AGACNP-BC Guest: Duvuru Geetha, MD On-demand webcast on the latest advances in diagnosing and managing patients with IgA nephropathy (IgAN), including the current data on new and emerging IgAN therapies.

Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease 26.12.2025

Host: Anne Marie Singh, MD On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.

Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline 26.12.2025

Host: Emily D. Clark, DO Guest: Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA Guest: Susan Scanland, MSN, CRNP, GNP-BC, CDP Guest: Anthony J. Viera, MD, MPH In this on-demand webcast, leading experts in brain health provide guidance for patient education, discussion, and management geared toward HCPs in primary care who are at the forefront of an aging population at risk of cognitive decline trying to...

Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease 26.12.2025

Host: Anne Marie Singh, MD On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.

Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline 26.12.2025

Host: Emily D. Clark, DO Guest: Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA Guest: Susan Scanland, MSN, CRNP, GNP-BC, CDP Guest: Anthony J. Viera, MD, MPH In this on-demand webcast, leading experts in brain health provide guidance for patient education, discussion, and management geared toward HCPs in primary care who are at the forefront of an aging population at risk of cognitive decline trying to...

Decoding EGPA: A Clinical Deep Dive Into Diagnosis and Treatment 23.12.2025

Host: Praveen Akuthota, MD Guest: Anisha Dua, MD, MPH Guest: Michael E. Wechsler, MD, MMSc On-demand webcast on the latest advances in diagnosing and managing patients with eosinophilic granulomatosis with polyangiitis (EGPA), including current data on new EGPA therapies and shared decision-making strategies to help patients achieve and maintain remission.

Decoding EGPA: A Clinical Deep Dive Into Diagnosis and Treatment 23.12.2025

Host: Praveen Akuthota, MD Guest: Anisha Dua, MD, MPH Guest: Michael E. Wechsler, MD, MMSc On-demand webcast on the latest advances in diagnosing and managing patients with eosinophilic granulomatosis with polyangiitis (EGPA), including current data on new EGPA therapies and shared decision-making strategies to help patients achieve and maintain remission.

When Topicals Fail: The New IPC Consensus Every Clinician Should Know 22.12.2025

Faculty: Linda Stein Gold, MD Faculty: Bruce Strober, MD, PhD This podcast reviews the International Psoriasis Council (IPC) 2025 guidance on reclassifying psoriasis severity and redefining failure of topical therapies. Clinical features such as high-impact disease sites, failure of topical treatment, or BSA >10% all factor into whether patients are candidates for systemic therapy in this new g...

When Topicals Fail: The New IPC Consensus Every Clinician Should Know 22.12.2025

Faculty: Linda Stein Gold, MD Faculty: Bruce Strober, MD, PhD This podcast reviews the International Psoriasis Council (IPC) 2025 guidance on reclassifying psoriasis severity and redefining failure of topical therapies. Clinical features such as high-impact disease sites, failure of topical treatment, or BSA >10% all factor into whether patients are candidates for systemic therapy in this new g...

Ascultă podcastul CME/CE în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice